The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-(2-Aminopyridin-4-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea ID: ALA4097599
Cas Number: 2092921-50-9
PubChem CID: 92045043
Max Phase: Preclinical
Molecular Formula: C24H32N6O2S
Molecular Weight: 468.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NC(=S)NCCCn2cncc2C)ccc1OCCCCc1ccnc(N)c1
Standard InChI: InChI=1S/C24H32N6O2S/c1-18-16-26-17-30(18)12-5-10-28-24(33)29-20-7-8-21(22(15-20)31-2)32-13-4-3-6-19-9-11-27-23(25)14-19/h7-9,11,14-17H,3-6,10,12-13H2,1-2H3,(H2,25,27)(H2,28,29,33)
Standard InChI Key: MXAZSKBTKUGBLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
0.0982 -4.0849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6530 -3.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1990 -4.3645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7904 -5.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0134 -4.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6311 -5.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8053 -3.6751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5136 -4.0826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2207 -3.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9291 -4.0803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6361 -3.6706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3445 -4.0781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6348 -2.8534 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.0515 -3.6684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7572 -4.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4638 -3.6700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4629 -2.8520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7496 -2.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0460 -2.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1695 -2.4413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1671 -1.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8736 -1.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8712 -0.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1720 -4.0778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1729 -4.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5777 0.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5753 0.8358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2817 1.2443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2797 2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5703 2.4721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8614 2.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8670 1.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1511 2.4584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
16 24 1 0
24 25 1 0
23 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
31 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.63Molecular Weight (Monoisotopic): 468.2307AlogP: 3.96#Rotatable Bonds: 12Polar Surface Area: 99.25Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.48CX Basic pKa: 7.72CX LogP: 3.29CX LogD: 2.78Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.02
References 1. Hoang VH, Tran PT, Cui M, Ngo VT, Ann J, Park J, Lee J, Choi K, Cho H, Kim H, Ha HJ, Hong HS, Choi S, Kim YH, Lee J.. (2017) Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design., 60 (6): [PMID:28234463 ] [10.1021/acs.jmedchem.7b00098 ] 2. Hoang VH, Ngo VTH, Cui M, Manh NV, Tran PT, Ann J, Ha HJ, Kim H, Choi K, Kim YH, Chang H, Macalino SJY, Lee J, Choi S, Lee J.. (2019) Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design., 62 (17): [PMID:31411468 ] [10.1021/acs.jmedchem.9b00751 ] 3. Van Manh N, Hoang VH, Ngo VTH, Ann J, Jang TH, Ha JH, Song JY, Ha HJ, Kim H, Kim YH, Lee J, Lee J.. (2021) Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design., 226 [PMID:34536669 ] [10.1016/j.ejmech.2021.113819 ]